PER 1.18% 8.4¢ percheron therapeutics limited

I was 'slightly' reassured by the last paragraph... which still...

  1. 69 Posts.
    lightbulb Created with Sketch. 51
    I was 'slightly' reassured by the last paragraph... which still reports the data is expected second half of 2024 Calendar Year.

    "Next Steps
    ATL1102 is currently the subject of an ongoing international phase IIb clinical trial in Duchenne muscular dystrophy, with data anticipated in 2H CY2024.
    "
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
-0.001(1.18%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.